PACS Group (PACS) Q3 2024 earnings summary

Executive summary

• Achieved 29.8% year-over-year revenue growth to $1.03 billion for Q3 2024, driven by facility acquisitions and higher patient days.

• Net income for Q3 2024 was $16.2 million, down 18.7% from Q3 2023, primarily due to increased costs and higher tax expense.

• Expanded operations to 276 facilities across 15 states, adding 46 skilled nursing and 22 assisted living facilities in the nine months ended September 30, 2024.

• Completed an IPO in April 2024 and a follow-on offering in September 2024, raising net proceeds of $423 million and $96.4 million, respectively.

Financial highlights

• Patient and resident service revenue rose 27.5% year-over-year to $2.88 billion for the nine months ended September 30, 2024.

• Operating income for the nine months was $51.1 million, down 64.8% from the prior year period.

• Adjusted EBITDA for Q3 2024 was $49.1 million; Adjusted EBITDAR was $121.7 million.

• Cash flow from operations increased to $302.8 million for the nine months, up from $73.4 million in the prior year.

• Cash and cash equivalents were $49.5 million as of September 30, 2024.

Outlook and guidance

• Management expects continued revenue growth from acquisitions and operational improvements.

• Cautions on regulatory and reimbursement risks, labor shortages, and ongoing legal and compliance matters.